Novolog 100 unit/ML flexpen 3ML
Ended Awarded
- Contract number
- SPE2DB25FSVZW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,265
Award facts
- Contract value 100% obligated
- $1,265.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,265.40 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of September 15, 2025. The contract represents a firm fixed price, non-set-aside delivery order executed on September 12, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award is a child contract under AmerisourceBergen's substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal vendor supplying an extensive portfolio of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract awards demonstrate significant capability in fulfilling competitive medical procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialized medical supplies. This particular delivery order for insulin represents a routine pharmaceutical supply transaction supporting military healthcare logistics requirements through DLA's established prime vendor contract structure.
Quick answers
Who was awarded contract SPE2DB25FSVZW?
SPE2DB25FSVZW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FSVZW worth?
The government has obligated $1,265 on SPE2DB25FSVZW.
Is contract SPE2DB25FSVZW an order under another contract?
Yes. SPE2DB25FSVZW is a delivery order under SPE2DB25D7067, an indefinite delivery contract.
Was contract SPE2DB25FSVZW competed?
The extent of competition for SPE2DB25FSVZW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award